1. Warner J, Lessell S. Neuro-ophthalmology of multiple sclerosis. Clin Neurosci.1994 ;2(3-4):180-8.
2. Nakajima H, Hosokawa T, Sugino M, Kimura F, Sugasawa J, Hanafusa T, et al. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis. BMC Neurol. 2010;10:45. [
DOI:10.1186/1471-2377-10-45] [
PMID] [
PMCID]
3. Patterson V, Heron J. Visual field abnormalities in multiple sclerosis. J Neurol Neurosurg Psychiatr.1980; 43(3):205209. [
DOI:10.1136/jnnp.43.3.205] [
PMID] [
PMCID]
4. Vidović T, Cerovski B, Vidović D, Cerovski J, Novak-Laus K. Inapparent visual field defects in multiple sclerosis patients. Colleg Antropol. 2005; 29 Suppl 1: 67-73.
5. Chin W , Fathi M. Atypical presentation of optic neuritis with unilateral inferior altitudinal visual field defect in multiple sclerosis. J Ophthalmol.2020;5. [
DOI:10.5603/OJ.2020.0026]
6. Kale N. Optic neuritis as an early sign of multiple sclerosis. Eye Brain. 2016; 8: 195-202. [
DOI:10.2147/EB.S54131] [
PMID] [
PMCID]
7. Pau D, Al Zubidi Nu, Yalamanchili S, et al. Optic neuritis. Eye. 2011; 25(7) : 833-842. [
DOI:10.1038/eye.2011.81] [
PMID] [
PMCID]
8. Hayreh SS. Pathogenesis of visual field defects. Role of the ciliary circulation. Br J Ophthalmol. 1970; 54(5): 289-311. [
DOI:10.1136/bjo.54.5.289] [
PMID] [
PMCID]
9. Hoorbakht H, Bagherkashi F. Optic neuritis, its differential diagnosis and management. Open Ophthalmol J. 2012; 6: 65-72. [
DOI:10.2174/1874364101206010065] [
PMID] [
PMCID]
10. Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol .2008; 65(6):727-732. [
DOI:10.1001/archneur.65.6.727]